PRISMAFLEX (EPA:ALPRI) | WebDisclosure

Basculer en Français

10761	Companies
231312	Keywords
159724	Articles
122983	Press releases

Home
Companies
PRISMAFLEX

BRIEF

published on 05/07/2024 at 18:05, 2 years 2 months ago

Prismaflex International announces divergent results for the 2023-2024 financial year

Financial Results Profitability Turnover Prismaflex International Printing Sector
PRESS RELEASE

published on 05/07/2024 at 18:00, 2 years 2 months ago

Chiffre d'affaires annuel 2023-2024 : 51,7 M EUR en ligne avec les attentes - Rentabilité attendue en nette amélioration
Prismaflex International annonce une baisse de chiffre d'affaires annuel de -9,8% mais prévoit des résultats bénéficiaires. Perspectives 2024-2025 axées sur la croissance et l'optimisation opérationnelle

Chiffre D'affaires Croissance Prismaflex International Résultats Bénéficiaires Optimisation Opérationnelle
PRESS RELEASE

published on 05/07/2024 at 18:00, 2 years 2 months ago

2023-2024 annual revenue: EUR 51.7 million, in line with expectations - Significant improvement in expected profitability
Prismaflex International reports on its annual consolidated sales figures for 2023-2024, highlighting a drop in Printing and Hardware activities while maintaining positive results

Financial Performance Prismaflex International Annual Sales Figures Printing Activity Hardware Activity

Accesswire

Published on 07/22/2026 at 15:00, 5 hours 51 minutes ago

Karbon-X Secures Technical Advisory Engagement for Nature-Based Carbon Project in Libya
Published on 07/22/2026 at 15:00, 5 hours 51 minutes ago

Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF) Due to Microvillus Inclusion Disease (MVID)
Published on 07/22/2026 at 14:50, 6 hours 1 minute ago

Hillcrest Enters AI Datacenter Ecosystem
Published on 07/22/2026 at 14:35, 6 hours 16 minutes ago

Wi2Wi Reports Significant Manufacturing Yield Improvement in Q2 2026
Published on 07/22/2026 at 14:30, 6 hours 21 minutes ago

As Ebola Death Toll Surpasses 930 Within Two Months, NanoViricides Has Applied to the DR Congo Regulatory Agency for Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola

View all ACCESSWIRE

EQS Group

Published on 07/22/2026 at 20:45, 5 minutes ago

Increase in Equity to Accelerate Growth
Published on 07/22/2026 at 20:44, 7 minutes ago

EQS-Adhoc: CHAPTERS Group AG: Successful Completion of Private Placement of the Capital Increase from Authorized Capital Resolved on July 22, 2026
Published on 07/22/2026 at 20:08, 42 minutes ago

EQS-Adhoc: FUCHS SE: Preliminary results for the first half of the year ahead of expectations and increase in the EBIT forecast for 2026
Published on 07/22/2026 at 19:35, 1 hour 15 minutes ago

Stabilus SE: Invitation to a web conference on Q3 FY2026 results on August 3, 2026
Published on 07/22/2026 at 19:29, 1 hour 21 minutes ago

EQS-Adhoc: Stabilus SE: Profit from operating activities and profit for the period significantly higher, adjusted FCF lower than in Q3 of the prior year; full-year forecast specified within the original ranges

Les Echos

Published on 07/22/2026 at 18:19, 2 hours 32 minutes ago

Covivio place avec succès 500 M€ d’obligations vertes à 7 ans
Published on 07/22/2026 at 18:19, 2 hours 32 minutes ago

Covivio successfully places €500 million of 7-year European Green Bonds
Published on 07/22/2026 at 17:45, 3 hours 6 minutes ago

Groupe CRIT : 2026 first half revenue: €1.67 billion (+2.3% on an organic basis).
Published on 07/22/2026 at 17:45, 3 hours 6 minutes ago

Groupe CRIT : Chiffre d’affaires du 1er semestre 2026 : 1,67 Md€ (+2,3% en organique).
Published on 07/22/2026 at 17:40, 3 hours 11 minutes ago

Report on share repurchases from 15 to 21 July 2026

View all LES ECHOS COMFI WIRE